viral hepatitis part 1 W5 Flashcards

1
Q

viral hepatitis types?

A

Hepatitis A/B/C/D/E
Hepatitis non-A/E

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what do viruses need to replicate

A

require host cells and its cellular biochemical machinery to replicate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what do viruses consist of

A

DNA/RNA enclosed in a protein coat (nucleocapsid) and sometimes a host cell derived envelope

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

how do viruses attach to host cells

A

viruses attach to host cell using receptor-binding proteins targeting host cell surface molecules that also serve as virus-specific receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

clinical symptoms of hepatitis?

A

jaundice
dark urine
clay-coloured stool
nausea and vomiting
loss of appetite
fever
abdominal pain
weakness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

biochemical blood tests for hepatitis?

A

liver enzymes (ALT, AST, ALP, GGT)
other liver proteins (albumin, prothrombin)
bilirubin (indirect, direct)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

serological and molecular tests for viral hepatitis?

A

enzymes immunosorbent assays (EIA)
molecular assays

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

serological and molecular tests for viral hepatitis - enzyme immunosorbent assays?

A

viral antigen
anti-viral antibody

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

serological and molecular tests for viral hepatitis - molecular assays?

A

PCR (viral load)
sequencing (genotype, antiviral resistance)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

transmission of hepatitis?

A

B/C/D - transmitted parentally
A/E - transmitted faecal-orally

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

parenteral transmission meaning?

A

transmitted outside of GI tract (eg sexual contact and blood)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

acute/chronic hepatitis types?

A

B/C/D - chronic
A/C/E - acute

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

who can hep D infect

A

only those who are already hep B positive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

which types of hepatitis are more stable and why

A

types transmitted faecal-orally, as must survive for a longer time outside the body

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

hepatitis A - family?

A

picornavirus (same as viruses causing meningitis, encephalitis)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

hepatitis A - incubation time?

A

10-50 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

who does hepatitis A mainly affect?

A

children and young adults

18
Q

hepatitis A - seasonality?

A

no seasonality

19
Q

hepatitis A - onset, resolution, fatality?

A

onset = abrupt with pyrexia
resolves spontaneously followed by life long immunity
fatality rate <0.5%

20
Q

hepatitis A - treatment?

A

supportive

21
Q

hepatitis A - test results

A

dramatic increase in liver enzymes

22
Q

hepatitis A - vaccine?

A

inactivated virus vaccine and immunoglobulin available

23
Q

HAV transmission?

A

transmitted via stool, contaminates water, infecting eg shellfish and vegetables

24
Q

HAV diagnosis?

A

diagnosed with antibodies in blood
IgM and IgG antibodies

25
Q

HAV outcome - children?

A

subclinical infection: 80-90%
icteric disease (jaundice): 5-20%
complete recovery: >98%
no chronic disease
fatality rate: 0.1%

26
Q

HAV outcome - adults?

A

subclinical infection: 10-25%
icteric disease: 75-90%
complete recovery: >98%
no chronic disease
fatality rate: 0.3-2.1%

27
Q

HBV - family and structure?

A

enveloped partially dsDNA hepadnavirus

28
Q

HBV incubation time?

A

40-180 days

29
Q

HBV mainly affects?

A

babies, young adults

30
Q

HBV seasonality?

A

no seasonality

31
Q

HBV onset?

A

insidious, sometimes apyrexia

32
Q

HBV outcome

A

remains in hepatocytes for life, may re-activate under immunosuppression
chronic infection develops in 5-10% of adults, associated with hepatocellular cancer

33
Q

HBV fatality rate?

A

up to 2% in icteric cases

34
Q

HBV vaccine?

A

recombinant HBV surface antigen vaccine and immunoglobulin avaliable

35
Q

HBV treatment?

A

interferon alpha or antivirals

36
Q

HBV transmission?

A

parenteral, vertical, sexual

37
Q

hepatitis B antigens?

A

surface antigen (envelope - active infection)
core antigen (nucleocapsid) - antibodies indicate recent infection)
E antigen (nucleocapsid) - active infection

38
Q

HBV prevalence in europe/north america/australia?

A

HBsAg 0.2-0.5%
Anti-HBs 4-6%
neonatal infection rare
childhood infection rate

39
Q

HBV prevalence in eastern europe, Mediterranean, former USSR, central and south america, south-west asia?

A

HBsAg 2-7%
Anti-HBs 20-55%
neonatal infection frequent
childhood infection frequent

40
Q

HBV prevalence in south-east asia, parts of china, sub-saharan africa?

A

HBsAg 8-20%
anti-HBs 70-95%
neonatal infection very frequent
childhood infection very frequent

41
Q

HBV infection outcomes in different age groups?

A

newborns have severe infections and high chances of chronic infections compared to older children and adults